Electroacupuncture combined with acarbose improves insulin sensitivity via peroxisome proliferator–activated receptor γ activation and produces a stronger glucose-lowering effect than acarbose alone in a rat model of steroid-induced insulin resistance

Abstract

Background:

Previous studies have reported that electroacupuncture (EA) induces a glucose-lowering effect by improving insulin resistance (IR) and reduces plasma free fatty acid (FFA) levels in rats with steroid-induced insulin resistance (SIIR). In addition, EA can activate cholinergic nerves and stimulate endogenous opioid peptides to lower plasma glucose in streptozotocin-induced hyperglycemic rats. The aim of this study was to investigate the glucose-lowering effects of 15 Hz EA at bilateral ST36 in combination with acarbose (ACA). We hypothesized that EA combined with ACA would produce a stronger glucose-lowering effect than ACA alone.

Methods:

In this study, normal Wistar rats and SIIR rats were randomly divided into two groups: ACA and ACA + EA. To explore the potential mechanisms underlying the glucose-lowering effect, plasma FFA/insulin and insulin transduction signal pathway proteins were assayed.

Results:

Combined ACA + EA treatment had a greater glucose-lowering effect than ACA alone in normal Wistar rats (−45% ± 3% vs −19% ± 3%, p < 0.001) and SIIR model rats (−43% ± 2% vs −16% ± 6%, p < 0.001). A significant reduction in plasma FFA levels, improvement in homeostatic model assessment of IR (HOMA-IR) index (−48.9% ± 4.0%, p < 0.001) and insulin sensitivity index (102% ± 16.9%, p < 0.001), and significant increases in insulin receptor substrate 1, glucose transporter 4, and peroxisome proliferator–activated receptor γ protein expressions in skeletal muscle, were also observed in the ACA + EA group of SIIR rats.

Conclusion:

Combined EA and ACA therapy had a greater glucose-lowering effect than ACA monotherapy; this combined therapy could be more effective at improving IR in SIIR rats, which may be related to a reduction in plasma FFA levels and an elevation of insulin signaling proteins. Whether this combined therapy has an effect in type 2 diabetes mellitus (T2DM) patients still needs to be explored.

Keywords

acarbose electroacupuncture free fatty acid insulin signal transduction steroid-induced insulin resistance

Get full access to this article

View all access options for this article.

References

American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care 2014; 37 (Suppl. 1): S81–S90.

Saltiel

Kahn

CR.

Insulin signalling and the regulation of glucose and lipid metabolism. Nature 2001; 414(6865): 799–806.

Olokoba

Obateru

Olokoba

LB.

Type 2 diabetes mellitus: a review of current trends. Oman Med J 2012; 27(4): 269–273.

Thomas

Gregg

Metformin; a review of its history and future: from lilac to longevity. Pediatr Diabetes 2017; 18(1): 10–16.

Tran

Zielinski

Roach

, et al. Pharmacologic treatment of type 2 diabetes: oral medications. Ann Pharmacother 2015; 49(5): 540–556.

Chang

Lin

Chi

, et al. An insulin-dependent hypoglycaemia induced by electroacupuncture at the Zhongwan (CV12) acupoint in diabetic rats. Diabetologia 1999; 42(2): 250–255.

Curry

Bennett

CH.

Stimulation of insulin secretion by beta-endorphins (1-27 & 1-31). Life Sci 1987; 40(21): 2053–2058.

Lee

Tzeng

, et al. Electroacupuncture-induced cholinergic nerve activation enhances the hypoglycemic effect of exogenous insulin in a rat model of streptozotocin-induced diabetes. Exp Diabetes Res 2011; 2011: 947138.

Tian

Cao

, et al. Effects of electroacupuncture stimulation at different spinal segmental levels in a rat model of diabetes mellitus. Acupunct Med 2018; 36(1): 29–35.

10.

Chang

Lin

, et al. Enhanced insulin sensitivity using electroacupuncture on bilateral Zusanli acupoints (ST 36) in rats. Life Sci 2006; 79(10): 967–971.

11.

Cabioglu

Ergene

Changes in levels of serum insulin, C-Peptide and glucose after electroacupuncture and diet therapy in obese women. Am J Chin Med 2006; 34(3): 367–376.

12.

Jung

Effects of pioglitazone and insulin on tight glycaemic control assessed by the continuous glucose monitoring system: a monocentric, parallel-cohort study. Clin Drug Investig 2005; 25(5): 347–352.

13.

Tan

Johns

Strand

, et al. Sustained effects of pioglitazone vs. glibenclamide on insulin sensitivity, glycaemic control, and lipid profiles in patients with type 2 diabetes. Diabet Med 2004; 21(8): 859–866.

14.

Zimmet

Shaw

Alberti

KG.

Preventing type 2 diabetes and the dysmetabolic syndrome in the real world: a realistic view. Diabet Med 2003; 20(9): 693–702.

15.

Liao

Sun

Lin

, et al. Electroacupuncture plus metformin lowers glucose levels and facilitates insulin sensitivity by activating MAPK in steroid-induced insulin-resistant rats. Acupunct Med 2015; 33(5): 388–394.

16.

Lin

Pai

Lee

, et al. Electroacupuncture and rosiglitazone combined therapy as a means of treating insulin resistance and type 2 diabetes mellitus: a randomized controlled trial. Evid Based Complement Alternat Med 2013; 2013: 969824.

17.

Chiniwala

Jabbour

Management of diabetes mellitus in the elderly. Curr Opin Endocrinol Diabetes Obes 2011; 18(2): 148–152.

18.

Chen

Cheng

Tzeng

, et al. Peroxisome proliferator-activated receptor activating hypoglycemic effect of Gardenia jasminoides Ellis aqueous extract and improvement of insulin sensitivity in steroid induced insulin resistant rats. BMC Complement Altern Med 2014; 14: 30.

19.

Tzeng

Lee

Chung

, et al. 15 Hz electroacupuncture at ST36 improves insulin sensitivity and reduces free fatty acid levels in rats with chronic dexamethasone-induced insulin resistance. Acupunct Med 2016; 34(4): 296–301.

20.

Romita

Yashpal

Hui-Chan

, et al. Intense peripheral electrical stimulation evokes brief and persistent inhibition of the nociceptive tail withdrawal reflex in the rat. Brain Res 1997; 761(2): 192–202.

21.

Lin

Tzeng

Lee

, et al. Acute effect of electroacupuncture at the Zusanli acupoints on decreasing insulin resistance as shown by lowering plasma free fatty acid levels in steroid-background male rats. BMC Complement Altern Med 2009; 9: 26.

22.

Takai

Sakura

[Insulinogenic index, HOMA-beta, disposition index]. Nihon Rinsho 2012; 70(Suppl. 3): 459–464.

23.

Haffner

Miettinen

Stern

MP.

The homeostasis model in the San Antonio Heart Study. Diabetes Care 1997; 20(7): 1087–1092.

24.

Girard

[Role of free fatty acids in the insulin resistance of non-insulin-dependent diabetes]. Diabete Metab 1995; 21(2): 79–88.

25.

Groop

Saloranta

Shank

, et al. The role of free fatty acid metabolism in the pathogenesis of insulin resistance in obesity and noninsulin-dependent diabetes mellitus. J Clin Endocrinol Metab 1991; 72(1): 96–107.

26.

Charles

Eschwege

Thibult

, et al. The role of non-esterified fatty acids in the deterioration of glucose tolerance in Caucasian subjects: results of the Paris Prospective Study. Diabetologia 1997; 40(9): 1101–1106.

27.

Sakoda

Ogihara

Anai

, et al. Dexamethasone-induced insulin resistance in 3T3-L1 adipocytes is due to inhibition of glucose transport rather than insulin signal transduction. Diabetes 2000; 49(10): 1700–1708.

28.

Rosenson

RS.

Effects of peroxisome proliferator-activated receptors on lipoprotein metabolism and glucose control in type 2 diabetes mellitus. Am J Cardiol 2007; 99(4A): 96B–104B.